Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“Heart‑transplant recipients typically undergo a series of heart biopsies after surgery.”
VerifiedConfidence: HIGH

Reasoning

Authoritative sources (ISHLT, AHA/ACC, UNOS) prescribe a schedule of endomyocardial biopsies beginning weekly and tapering over the first year, and a multicenter study shows 96% of recipients receive at least one biopsy with a median of seven in the first year. While newer non‑invasive tests can lower the number of biopsies, they supplement rather than replace the typical series, so the claim that recipients typically undergo a series of biopsies is well‑supported.

On confidence: Multiple primary guidelines and large cohort data consistently describe routine surveillance biopsies as standard post‑transplant care.

Important context

Emerging non‑invasive monitoring (e.g., AlloMap, imaging) can reduce biopsy frequency in some patients, and European centres may shift to quarterly biopsies after six months if markers are stable, but the baseline practice remains a series of scheduled biopsies.

Evidence

Supporting (4)

Contradicting (1)

Contextual (1)

  • Tier 2 — Independent reportingindependent origin
    ESC 2023 Position Paper on Heart‑Transplant Surveillance

    "European centres are increasingly adopting imaging‑based surveillance, decreasing routine endomyocardial biopsies to quarterly after six months, provided non‑invasive markers are stable."

Limitations

Evidence is drawn from guidelines and studies primarily in North America and Europe; practices in other regions may differ, and ongoing advances could change the standard of care faster than the cited sources reflect.

Last verified:
Sep 26, 2026, 4:52 PM CDT
Pipeline:
0.1.0
Claim type:
Factual

Where this claim appeared

Young organs may not be a fountain of youth for recipients

MIT Technology Review · Jessica Hamzelou